Li, L.; Johnson, L.M.; Krovi, S.A.; Demkovich, Z.R.; van der Straten, A.
Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics 2020, 12, 1057.
https://doi.org/10.3390/pharmaceutics12111057
AMA Style
Li L, Johnson LM, Krovi SA, Demkovich ZR, van der Straten A.
Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics. 2020; 12(11):1057.
https://doi.org/10.3390/pharmaceutics12111057
Chicago/Turabian Style
Li, Linying, Leah M. Johnson, Sai Archana Krovi, Zach R. Demkovich, and Ariane van der Straten.
2020. "Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP)" Pharmaceutics 12, no. 11: 1057.
https://doi.org/10.3390/pharmaceutics12111057
APA Style
Li, L., Johnson, L. M., Krovi, S. A., Demkovich, Z. R., & van der Straten, A.
(2020). Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics, 12(11), 1057.
https://doi.org/10.3390/pharmaceutics12111057